GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
1.8k
c/trialwatch·posted 5 months ago by u/joaquin_stanescu

small win: SURMOUNT stopped being a problem at week 65

Trial Data Slow Clap ×4 Sourced ×3

Right, the SURMOUNT question again, but with numbers this time.

I have 5 data points over 6 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign.

The thing I would flag for anyone new: the effect I am describing showed up at week 60, not week 14. People give up long before the interesting part.

Interested in whether this matches other people's logs or whether I am an outlier.

2,140 up / 302 down88% upvoted52 commentsid 59fiox15 Feb 2026

52 comments

30 in this archive, depth 6

best — the order this archive was captured in

u/marit_laurent131 points·5 months ago

Disagree. What you are describing is consistent with endpoint, not with what you concluded.

replysharereportpermalink
[deleted]191 points·5 months ago

[deleted]

replysharereportpermalink
u/forest_plot_fionaMOD55 points·5 months ago

Removed a chain here. The rule is one line long and it is not negotiable.

replysharereportpermalink
u/hugo_norgaard110 points·5 months ago·edited
genuine question, not being difficult: how do you know
replysharereportpermalink
u/curious_panel_only67 points·5 months ago

Yeah, absolute numbers matter more than the press release.

replysharereportpermalink
u/milos_vanhecke57 points·5 months ago

Not convinced. The evidence does not support that reading.

replysharereportpermalink
u/joaquin_stanescuOP40 points·5 months ago

phase 2 is not phase 3, smaller n and shorter trial

replysharereportpermalink
u/prior_auth_painappeals21 points·5 months ago·edited

press release TRIUMPH posts must be flaired until a publication exists

replysharereportpermalink
u/rina_sobczak52 points·5 months ago

STEP, SURMOUNT, SURPASS, SELECT, FLOW, TRIUMPH — read the appendix

replysharereportpermalink
u/annika_fonseca33 points·5 months ago

I am going to push back on this slightly.

replysharereportpermalink
u/curious_panel_only22 points·5 months ago

STEP, SURMOUNT, SURPASS, SELECT, FLOW, TRIUMPH — read the appendix

replysharereportpermalink
u/renal_outcomes_rnephro-curious12 points·5 months ago

the discontinuation arms are the interesting part, not the STEP endpoints

replysharereportpermalink
u/pancreatitis_scare6 points·5 months ago

give the trial name, phase, n, and primary endpoint in the body

replysharereportpermalink
u/paper_trail_paulavetting-15 points·5 months ago

STEP, SURMOUNT, SURPASS, SELECT, FLOW, TRIUMPH — read the appendix

replysharereportpermalink
u/joaquin_stanescuOP1 point·5 months ago

Yeah, absolute numbers matter more than the press release.

replysharereportpermalink
u/nordic_pricing0 points·5 months ago

dropout handling matters, especially on GI-heavy populations

replysharereportpermalink
u/hsa_math1 point·5 months ago

Strongly agree. Phase 2 is investigational, not conclusive.

replysharereportpermalink
u/zaid_roos1 point·5 months ago

give the trial name, phase, n, and primary endpoint in the body

replysharereportpermalink
load more comments (1) →
u/formulary_fighterappeals27 points·5 months ago

the 18 week readout is different from the 6 week readout

replysharereportpermalink
u/yusuf_achebe18 points·5 months ago

phase 2 is not phase 3, smaller n and shorter trial

replysharereportpermalink
u/hedda_adeyemi5 points·5 months ago·edited

phase 2 is not phase 3, smaller n and shorter trial

Disagree on that part. 99.0% and 98.9% on the same vial is normal.

replysharereportpermalink
u/nora_oyelaran0 points·5 months ago

STEP, SURMOUNT, SURPASS, SELECT, FLOW, TRIUMPH — read the appendix

replysharereportpermalink
u/week_one_wanda12 points·5 months ago

I am going to push back on this slightly.

replysharereportpermalink
u/joaquin_stanescu32 points·5 months ago

You have restated the marketing copy. What is the actual substance here.

replysharereportpermalink
u/arne_ilunga37 points·5 months ago

off-label use data is different from approved-indication data

replysharereportpermalink
u/forest_plot_fionastats17 points·5 months ago

press release SURPASS posts must be flaired until a publication exists

replysharereportpermalink
u/adaeze_weiss13 points·5 months ago

press release hazard ratio posts must be flaired until a publication exists

replysharereportpermalink
u/emil_agyeman19 points·5 months ago

I love that this community will spend 40 comments on a detail. That pedantry is why the numbers here matter.

replysharereportpermalink
u/alcohol_aversion11 points·5 months ago

Strongly agree. Phase 2 is investigational, not conclusive.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.